Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLFS BioLife Solutions	$24.50 +0.7%	$22.16	$19.10 ▼ $29.55	$1.17B	1.76	484,337 shs	543,714 shs
MDXG MiMedx Group	$7.19 +1.1%	$6.57	$5.47 ▼ $10.14	$1.06B	1.79	693,466 shs	452,950 shs
NNOX Nano-X Imaging	$4.26 -3.6%	$5.05	$3.75 ▼ $11.00	$246.14M	1.95	1.78 million shs	1.55 million shs
PLSE Pulse Biosciences	$15.68 -3.0%	$15.47	$13.77 ▼ $25.00	$1.05B	1.6	174,300 shs	120,923 shs

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLFS BioLife Solutions	0.00%	+7.32%	+16.85%	+6.10%	-5.84%
MDXG MiMedx Group	0.00%	+1.28%	+10.75%	-0.70%	+13.58%
NNOX Nano-X Imaging	0.00%	-4.95%	-14.01%	-19.34%	-38.70%
PLSE Pulse Biosciences	0.00%	+9.86%	+7.02%	-5.66%	-14.99%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLFS BioLife Solutions	3.3972 of 5 stars	3.6	3.0	0.0	3.9	2.5	0.6
MDXG MiMedx Group	3.1985 of 5 stars	3.5	4.0	0.0	3.2	1.7	0.6
NNOX Nano-X Imaging	2.1391 of 5 stars	3.8	2.0	0.0	2.2	0.0	0.6
PLSE Pulse Biosciences	3.8342 of 5 stars	3.5	0.0	4.2	1.8	4.2	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLFS BioLife Solutions	3.13	Buy	$31.29	27.70% Upside
MDXG MiMedx Group	3.00	Buy	$12.00	66.90% Upside
NNOX Nano-X Imaging	3.50	Strong Buy	$8.50	99.53% Upside
PLSE Pulse Biosciences	3.00	Buy	$22.00	40.31% Upside

Current Analyst Ratings Breakdown

Latest NNOX, BLFS, MDXG, and PLSE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$10.00 ➝ $8.00
8/11/2025	BLFS BioLife Solutions	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/11/2025	NNOX Nano-X Imaging	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/8/2025	BLFS BioLife Solutions	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00 ➝ $32.00
7/31/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$11.00 ➝ $12.00
7/22/2025	BLFS BioLife Solutions	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$30.00
7/15/2025	MDXG MiMedx Group	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$11.00
7/14/2025	NNOX Nano-X Imaging	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
7/7/2025	PLSE Pulse Biosciences	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$22.00
6/6/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$10.00
5/23/2025	NNOX Nano-X Imaging	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$15.00 ➝ $10.00

(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLFS BioLife Solutions	$93.47M	12.56	$0.12 per share	198.67	$7.52 per share	3.26
MDXG MiMedx Group	$348.88M	3.05	$0.34 per share	21.46	$1.31 per share	5.49
NNOX Nano-X Imaging	$11.28M	21.82	N/A	N/A	$3.27 per share	1.30
PLSE Pulse Biosciences	$700K	1,507.07	N/A	N/A	$1.87 per share	8.39

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLFS BioLife Solutions	-$20.18M	-$0.12	N/A	N/A	N/A	-5.39%	0.16%	0.14%	N/A
MDXG MiMedx Group	$42.42M	$0.21	34.24	22.47	N/A	8.84%	23.03%	17.09%	10/29/2025 (Estimated)
NNOX Nano-X Imaging	-$53.52M	-$0.90	N/A	N/A	N/A	-468.29%	-32.09%	-28.73%	N/A
PLSE Pulse Biosciences	-$53.58M	-$1.05	N/A	∞	N/A	N/A	-63.19%	-54.98%	10/29/2025 (Estimated)

Latest NNOX, BLFS, MDXG, and PLSE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	NNOX Nano-X Imaging	-$0.15	-$0.23	-$0.08	-$0.23	$3.20 million	$3.04 million
8/12/2025	Q2 2025	PLSE Pulse Biosciences	-$0.26	-$0.28	-$0.02	-$0.28	$0.50 million	N/A
8/7/2025	Q2 2025	BLFS BioLife Solutions	-$0.02	-$0.33	-$0.31	-$0.33	$23.71 million	$25.42 million
7/30/2025	Q2 2025	MDXG MiMedx Group	$0.06	$0.10	+$0.04	$0.06	$90.79 million	$98.61 million
5/22/2025	Q1 2025	NNOX Nano-X Imaging	-$0.23	-$0.21	+$0.02	-$0.21	$3.98 million	$3.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLFS BioLife Solutions	N/A	N/A	N/A	N/A	N/A
MDXG MiMedx Group	N/A	N/A	N/A	N/A	N/A
NNOX Nano-X Imaging	N/A	N/A	N/A	N/A	N/A
PLSE Pulse Biosciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLFS BioLife Solutions	0.03	4.43	3.45
MDXG MiMedx Group	0.08	4.39	3.90
NNOX Nano-X Imaging	N/A	4.19	5.16
PLSE Pulse Biosciences	N/A	12.05	15.58

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BLFS BioLife Solutions	93.24%
MDXG MiMedx Group	79.15%
NNOX Nano-X Imaging	21.49%
PLSE Pulse Biosciences	76.95%

Insider Ownership

Company	Insider Ownership
BLFS BioLife Solutions	2.20%
MDXG MiMedx Group	1.70%
NNOX Nano-X Imaging	N/A
PLSE Pulse Biosciences	71.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BLFS BioLife Solutions	440	47.91 million	46.85 million	Optionable
MDXG MiMedx Group	870	147.96 million	145.44 million	Optionable
NNOX Nano-X Imaging	190	57.78 million	N/A	Optionable
PLSE Pulse Biosciences	140	67.28 million	19.17 million	Optionable

NNOX, BLFS, MDXG, and PLSE Headlines

Recent News About These Companies

Pulse Biosciences (NASDAQ:PLSE) Trading Down 5.2% - Time to Sell?

August 17 at 1:40 PM | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Trading Up 7.1% - What's Next?

August 15 at 2:52 PM | marketbeat.com

Pulse Biosciences (NASDAQ:PLSE) Releases Earnings Results

August 14, 2025 | marketbeat.com

Pulse Biosciences Reports Q2 2025 Progress and Results

August 13, 2025 | msn.com

Pulse Biosciences, Inc. (PLSE) Q2 2025 Earnings Call Transcript

August 12, 2025 | seekingalpha.com

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

August 12, 2025 | businesswire.com

Pandora Wealth Inc. Takes Position in Pulse Biosciences, Inc (NASDAQ:PLSE)

August 10, 2025 | marketbeat.com

Pulse Biosciences (PLSE) to Release Earnings on Tuesday

August 6, 2025 | marketbeat.com

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

August 1, 2025 | finance.yahoo.com

Pulse Biosciences (NASDAQ:PLSE) Trading 2% Higher - Should You Buy?

August 1, 2025 | marketbeat.com

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

July 29, 2025 | businesswire.com

Oppenheimer Initiates Coverage of Pulse Biosciences (PLSE) with Outperform Recommendation

July 8, 2025 | msn.com

Insider Purchases Worth US$2.70m See Losses As Pulse Biosciences Market Value Drops To US$1.1b

June 17, 2025 | finance.yahoo.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) CTO Darrin Uecker Sells 15,000 Shares

June 17, 2025 | insidertrades.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 23, 2025 | businesswire.com

Pulse Biosciences, Inc. (NASDAQ:PLSE) insiders have significant skin in the game with 73% ownership

May 21, 2025 | uk.finance.yahoo.com

Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript

May 10, 2025 | seekingalpha.com

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

May 6, 2025 | businesswire.com

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

May 2, 2025 | finance.yahoo.com

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

April 25, 2025 | businesswire.com

Pulse Biosciences (NASDAQ:PLSE) Is In A Strong Position To Grow Its Business

April 24, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX, BLFS, MDXG, and PLSE Company Descriptions

BioLife Solutions NASDAQ:BLFS

$24.50 +0.16 (+0.66%)

Closing price 04:00 PM Eastern

Extended Trading

$24.49 -0.01 (-0.04%)

As of 04:10 PM Eastern

BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.

MiMedx Group NASDAQ:MDXG

$7.19 +0.08 (+1.13%)

Closing price 04:00 PM Eastern

Extended Trading

$7.15 -0.04 (-0.61%)

As of 04:54 PM Eastern

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Nano-X Imaging NASDAQ:NNOX

$4.26 -0.16 (-3.62%)

Closing price 04:00 PM Eastern

Extended Trading

$4.28 +0.02 (+0.47%)

As of 05:08 PM Eastern

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.

Pulse Biosciences NASDAQ:PLSE

$15.68 -0.48 (-2.97%)

Closing price 04:00 PM Eastern

Extended Trading

$15.72 +0.04 (+0.22%)

As of 05:07 PM Eastern

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time